CENTER VALLEY, PA--(Marketwired - July 03, 2014) - Aesculap, Inc. is pleased to announce the availability of Lyoplant® Onlay, a biological, collagen based, absorbable dura substitution consisting of a bilayer membrane, designed to provide an elevated ease of use. The revolutionary product allows for a simple onlay application with the opportunity to incorporate suture fixation, if necessary.
Lyoplant Onlay is indicated as a dura substitute for the repair of the dura mater. To learn more about Lyoplant Onlay, visit aesculapusa.com/products/neurosurgery/dura-substitutesor contact your local Aesculap Sales Representative.
*Biomechanical data is on file at Aesculap, Inc. All testing results are based on averages. Tensile strength and suture retention testing were performed in a rehydrated state.
About Aesculap, Inc.
Aesculap, Inc., a B. Braun company, is part of a 175-year-old global organization focused on meeting the needs of an ever-changing healthcare community. Through close collaboration with its customers, Aesculap provides advanced technologies for general surgery, neurosurgery and closure technologies. Aesculap continues a proud heritage of leadership and responsiveness as we strive to deliver products and services that improve the quality of patients' lives. For more information, call 800-282-9000 or visit aesculapusa.com.
The following files are available for download: